Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
PNTG vs ADUS vs ENSG vs NVST vs NHC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Equipment & Services
Medical - Care Facilities
PNTG vs ADUS vs ENSG vs NVST vs NHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Equipment & Services | Medical - Care Facilities |
| Market Cap | $1.25B | $1.86B | $10.02B | $3.95B | $2.95B |
| Revenue (TTM) | $1.02B | $1.45B | $5.27B | $2.81B | $1.51B |
| Net Income (TTM) | $30M | $100M | $363M | $68M | $124M |
| Gross Margin | 11.1% | 32.5% | 15.2% | 55.1% | 29.8% |
| Operating Margin | 5.6% | 9.8% | 8.5% | 9.0% | 8.6% |
| Forward P/E | 26.7x | 14.3x | 22.7x | 17.0x | 23.7x |
| Total Debt | $453M | $209M | $4.15B | $1.71B | $87M |
| Cash & Equiv. | $17M | $82M | $504M | $1.21B | $111M |
PNTG vs ADUS vs ENSG vs NVST vs NHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Pennant Group, … (PNTG) | 100 | 140.8 | +40.8% |
| Addus HomeCare Corp… (ADUS) | 100 | 100.6 | +0.6% |
| The Ensign Group, I… (ENSG) | 100 | 392.2 | +292.2% |
| Envista Holdings Co… (NVST) | 100 | 114.7 | +14.7% |
| National HealthCare… (NHC) | 100 | 281.5 | +181.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PNTG vs ADUS vs ENSG vs NVST vs NHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PNTG is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 36.3%, EPS growth 18.3%, 3Y rev CAGR 26.0%
- 36.3% revenue growth vs NVST's 8.3%
ADUS ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.57, Low D/E 19.2%, current ratio 1.80x
- PEG 0.71 vs NVST's 11.37
- Lower P/E (14.3x vs 23.7x), PEG 0.71 vs 1.03
ENSG is the clearest fit if your priority is long-term compounding.
- 7.4% 10Y total return vs NHC's 225.1%
- Beta 0.38 vs NVST's 1.63
Among these 5 stocks, NVST doesn't own a clear edge in any measured category.
NHC carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.63, yield 1.3%
- Beta 0.63, yield 1.3%, current ratio 1.77x
- 8.2% margin vs NVST's 2.4%
- 1.3% yield, 12-year raise streak, vs ENSG's 0.1%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.3% revenue growth vs NVST's 8.3% | |
| Value | Lower P/E (14.3x vs 23.7x), PEG 0.71 vs 1.03 | |
| Quality / Margins | 8.2% margin vs NVST's 2.4% | |
| Stability / Safety | Beta 0.38 vs NVST's 1.63 | |
| Dividends | 1.3% yield, 12-year raise streak, vs ENSG's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +102.2% vs ADUS's -10.1% | |
| Efficiency (ROA) | 10.6% ROA vs NVST's 1.2%, ROIC 9.9% vs 4.8% |
PNTG vs ADUS vs ENSG vs NVST vs NHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PNTG vs ADUS vs ENSG vs NVST vs NHC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHC leads in 3 of 6 categories
ADUS leads 1 • PNTG leads 0 • ENSG leads 0 • NVST leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NVST and NHC each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 5.2x PNTG's $1.0B. NHC is the more profitable business, keeping 8.2% of every revenue dollar as net income compared to NVST's 2.4%. On growth, PNTG holds the edge at +36.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $1.4B | $5.3B | $2.8B | $1.5B |
| EBITDAEarnings before interest/tax | $66M | $159M | $558M | $342M | $175M |
| Net IncomeAfter-tax profit | $30M | $100M | $363M | $68M | $124M |
| Free Cash FlowCash after capex | $47M | $137M | $406M | $220M | $168M |
| Gross MarginGross profit ÷ Revenue | +11.1% | +32.5% | +15.2% | +55.1% | +29.8% |
| Operating MarginEBIT ÷ Revenue | +5.6% | +9.8% | +8.5% | +9.0% | +8.6% |
| Net MarginNet income ÷ Revenue | +3.0% | +6.9% | +6.9% | +2.4% | +8.2% |
| FCF MarginFCF ÷ Revenue | +4.6% | +9.5% | +7.7% | +7.8% | +11.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +36.0% | +7.7% | +18.4% | +14.4% | -1.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.1% | +17.2% | +21.9% | +130.0% | +9.7% |
Valuation Metrics
ADUS leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 19.1x trailing earnings, ADUS trades at a 78% valuation discount to NVST's 86.6x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.95x vs NVST's 57.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.2B | $1.9B | $10.0B | $4.0B | $2.9B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $2.0B | $13.7B | $4.4B | $2.9B |
| Trailing P/EPrice ÷ TTM EPS | 42.74x | 19.11x | 29.36x | 86.57x | 24.62x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.73x | 14.28x | 22.68x | 16.97x | 23.69x |
| PEG RatioP/E ÷ EPS growth rate | 4.25x | 0.95x | 2.13x | 57.98x | 1.07x |
| EV / EBITDAEnterprise value multiple | 28.11x | 12.79x | 25.40x | 13.01x | 15.51x |
| Price / SalesMarket cap ÷ Revenue | 1.32x | 1.30x | 1.98x | 1.45x | 1.95x |
| Price / BookPrice ÷ Book value/share | 3.39x | 1.69x | 4.52x | 1.32x | 2.75x |
| Price / FCFMarket cap ÷ FCF | 47.47x | 17.89x | 27.02x | 17.15x | 19.82x |
Profitability & Efficiency
NHC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $2 for NVST. NHC carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs PNTG's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.4% | +9.3% | +16.6% | +2.2% | +11.6% |
| ROA (TTM)Return on assets | +3.5% | +7.0% | +6.8% | +1.2% | +10.6% |
| ROICReturn on invested capital | +5.6% | +8.8% | +7.0% | +4.8% | +9.9% |
| ROCEReturn on capital employed | +7.3% | +10.9% | +10.2% | +4.9% | +11.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.21x | 0.19x | 1.86x | 0.55x | 0.08x |
| Net DebtTotal debt minus cash | $436M | $127M | $3.7B | $496M | -$24M |
| Cash & Equiv.Liquid assets | $17M | $82M | $504M | $1.2B | $111M |
| Total DebtShort + long-term debt | $453M | $209M | $4.2B | $1.7B | $87M |
| Interest CoverageEBIT ÷ Interest expense | 16.52x | 14.45x | 88.33x | 12.76x | 61.40x |
Total Returns (Dividends Reinvested)
NHC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHC five years ago would be worth $28,418 today (with dividends reinvested), compared to $5,353 for NVST. Over the past 12 months, NHC leads with a +102.2% total return vs ADUS's -10.1%. The 3-year compound annual growth rate (CAGR) favors NHC at 51.1% vs NVST's -11.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.0% | -6.6% | -1.4% | +11.8% | +45.3% |
| 1-Year ReturnPast 12 months | +27.4% | -10.1% | +26.0% | +36.4% | +102.2% |
| 3-Year ReturnCumulative with dividends | +205.5% | +19.0% | +85.9% | -30.4% | +245.3% |
| 5-Year ReturnCumulative with dividends | -1.8% | +3.4% | +105.6% | -46.5% | +184.2% |
| 10-Year ReturnCumulative with dividends | +137.9% | +411.7% | +738.2% | -13.3% | +225.1% |
| CAGR (3Y)Annualised 3-year return | +45.1% | +6.0% | +23.0% | -11.4% | +51.1% |
Risk & Volatility
Evenly matched — ENSG and NHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than NVST's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHC currently trades 99.4% from its 52-week high vs ENSG's 78.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.57x | 0.38x | 1.63x | 0.63x |
| 52-Week HighHighest price in past year | $37.54 | $124.44 | $218.00 | $30.42 | $189.95 |
| 52-Week LowLowest price in past year | $21.73 | $90.89 | $134.68 | $16.41 | $93.54 |
| % of 52W HighCurrent price vs 52-week peak | +95.6% | +80.0% | +78.6% | +79.7% | +99.4% |
| RSI (14)Momentum oscillator 0–100 | 75.1 | 51.2 | 22.0 | 36.4 | 53.4 |
| Avg Volume (50D)Average daily shares traded | 238K | 236K | 364K | 2.5M | 118K |
Analyst Outlook
NHC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PNTG as "Buy", ADUS as "Buy", ENSG as "Buy", NVST as "Hold". Consensus price targets imply 29.7% upside for ENSG (target: $222) vs 9.3% for PNTG (target: $39). For income investors, NHC offers the higher dividend yield at 1.31% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | — |
| Price TargetConsensus 12-month target | $39.25 | $128.67 | $222.33 | $27.44 | — |
| # AnalystsCovering analysts | 7 | 16 | 13 | 19 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.1% | — | +1.3% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 12 | — | 12 |
| Dividend / ShareAnnual DPS | — | — | $0.24 | — | $2.47 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | +4.2% | +0.5% |
NHC leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). ADUS leads in 1 (Valuation Metrics). 2 tied.
PNTG vs ADUS vs ENSG vs NVST vs NHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PNTG or ADUS or ENSG or NVST or NHC a better buy right now?
For growth investors, The Pennant Group, Inc.
(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus 8. 3% for Envista Holdings Corp (NVST). Addus HomeCare Corporation (ADUS) offers the better valuation at 19. 1x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate The Pennant Group, Inc. (PNTG) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PNTG or ADUS or ENSG or NVST or NHC?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 19.
1x versus Envista Holdings Corp at 86. 6x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 71x versus Envista Holdings Corp's 11. 37x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PNTG or ADUS or ENSG or NVST or NHC?
Over the past 5 years, National HealthCare Corporation (NHC) delivered a total return of +184.
2%, compared to -46. 5% for Envista Holdings Corp (NVST). Over 10 years, the gap is even starker: ENSG returned +738. 2% versus NVST's -13. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PNTG or ADUS or ENSG or NVST or NHC?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 38β versus Envista Holdings Corp's 1. 63β — meaning NVST is approximately 331% more volatile than ENSG relative to the S&P 500. On balance sheet safety, National HealthCare Corporation (NHC) carries a lower debt/equity ratio of 8% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PNTG or ADUS or ENSG or NVST or NHC?
By revenue growth (latest reported year), The Pennant Group, Inc.
(PNTG) is pulling ahead at 36. 3% versus 8. 3% for Envista Holdings Corp (NVST). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PNTG or ADUS or ENSG or NVST or NHC?
National HealthCare Corporation (NHC) is the more profitable company, earning 7.
9% net margin versus 1. 7% for Envista Holdings Corp — meaning it keeps 7. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 5. 4% for PNTG. At the gross margin level — before operating expenses — NHC leads at 67. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PNTG or ADUS or ENSG or NVST or NHC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 71x versus Envista Holdings Corp's 11. 37x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 3x forward P/E versus 26. 7x for The Pennant Group, Inc. — 12. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENSG: 29. 7% to $222. 33.
08Which pays a better dividend — PNTG or ADUS or ENSG or NVST or NHC?
In this comparison, NHC (1.
3% yield), ENSG (0. 1% yield) pay a dividend. PNTG, ADUS, NVST do not pay a meaningful dividend and should not be held primarily for income.
09Is PNTG or ADUS or ENSG or NVST or NHC better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), +738. 2% 10Y return). Envista Holdings Corp (NVST) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ENSG: +738. 2%, NVST: -13. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PNTG and ADUS and ENSG and NVST and NHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PNTG is a small-cap high-growth stock; ADUS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; NVST is a small-cap quality compounder stock; NHC is a small-cap high-growth stock. NHC pays a dividend while PNTG, ADUS, ENSG, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.